Drawing for CANNACRUNCH

USPTO serial 88425693

CANNACRUNCH

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
TRUSILO, KELLY JEAN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CANNACRUNCH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Courtney Thompson

Courtney Thompson Fredrikson & Byron, P.A.200 South Sixth Street, Suite 4000Minneapolis, MN 55402UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003Bath additives, namely, bath herbs, bath oils, bath oils for cosmetic purposes; beauty care cosmetics; beauty creams for body care; beauty gels; beauty lotions; body and beauty care cosmetics; body creams; body oils; cosmetic creams; cosmetic oils; cosmetics and make-up; face and body lotions; face and body milk; face lotion; hair care preparations; hair styling preparations; hand cream; hand lotions; non-medicated lip care preparations; lip conditioners; lip glosses; non-medicated liquid soaps; massage creams; massage oils; non-medicated bubble bath preparations; non-medicated preparations for the care of hair; non-medicated preparations for the care of skin; non-medicated preparations for the care of the scalp; non-medicated skin care preparations; oils for toiletry purposes; skin care preparations; skin creams; skin emollients; skin lotions; skin soap; soaps for body care, namely, cream soaps, bath soaps, bar soaps, paper soaps; soaps for personal use, namely, cream soaps, bath soaps, bar soaps, paper soaps; all of the foregoing derived from hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basisACTIVE—
005Hemp related products, namely, medicinal oils and salves; concentrated medicated pastes for the teeth and gums, for the hair and scalp, and for use on skin rashes; tinctures, tablets and capsules for treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders and anxiety; medicated oils, salves, and concentrated pastes for the treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders, and anxiety; tinctures, tablets and capsules each containing resins and oils derived from hemp for treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders and anxiety; nutraceuticals for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing derivatives of hemp, namely, resins and oils for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; medicated topical skin creams, medicated bar and liquid soaps; medicated bath additives, namely, bath herbs, bath oils, bath salts; medicated body creams, medicated body oils, medicated face and body lotions, medicated face and body milk, medicated face lotion, and medicated skin care preparations each of the foregoing containing derivatives of hemp for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid; personal sexual lubricants; transdermal patches containing derivatives of hemp for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oral sprays for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; hemp derivatives for medicinal use; hemp related products, namely, oils for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oils derived from hemp for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; all of the foregoing derived from hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBDACTIVE—
029Oils derived from hemp for use as comestibles, namely, edible oil for cooking, edible oils and fats, processed oils for food; hemp related products, namely, oils for use as comestibles, namely, edible oil for cooking, edible oils and fats, processed oils for food; food products containing hemp, resins, and oils, namely, butter; all of the foregoing derived from hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBDACTIVE—
030Food products containing hemp and derivatives thereof, namely, chocolates, cookies, brownies, candy and granola-based, cereal based food energy bars; tea, namely, teas containing hemp and derivatives thereof; all of the foregoing derived from hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBDACTIVE—
031Live hemp plants; all of the foregoing derived from hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basisACTIVE—
032Smoothies, fruit beverages and fruit juices, carbonated soft drinks, and energy drinks each containing hemp and derivatives thereof; all of the foregoing derived from hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBDACTIVE—
034Smokers' articles, namely, grinders for use with hemp, dried hemp for smoking; derivatives of hemp, namely, processed resins and oils in the nature of liquids for use in electronic cigarettes and oral smokeless vaporizers; e-liquids comprised of hemp derivatives for use in electronic cigarettes and oral smokeless vaporizers for recreational use; smokers' articles, namely, smoking pipes, oral vaporizers for smokers; all of the foregoing derived from hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD or exclusively for use with goods derived from hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; smokers' articles, namely, pouches for use with hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, lighters for smokersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 8, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 8, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 7, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 5, 2022EX1GSOU EXTENSION 1 GRANTED—
Oct 5, 2022EXT1SOU EXTENSION 1 FILED—
Oct 5, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 5, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 24, 2022ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Dec 21, 2021CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Dec 21, 2021APETASSIGNED TO PETITION STAFF—
Dec 3, 2021EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Oct 25, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 25, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 25, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 25, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 25, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 3, 2021ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Aug 17, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 17, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 28, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 15, 2021PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 15, 2021ALIEASSIGNED TO LIE—
Jul 15, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 15, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Jul 15, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 15, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 15, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 14, 2021ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jun 8, 2021PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
May 26, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 25, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 25, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 25, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 30, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 30, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 30, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 22, 2020GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
May 22, 2020GNSLLETTER OF SUSPENSION E-MAILED—
May 22, 2020CNSLSUSPENSION LETTER WRITTEN—
Apr 23, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 22, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 22, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 23, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 23, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 23, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 15, 2019DOCKASSIGNED TO EXAMINER—
May 30, 2019DOCKASSIGNED TO EXAMINER—
May 28, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 14, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance